Aastrom Biosciences to Host First Quarter 2014 Investor Call on May 15, 2014

[GlobeNewswire] – ANN ARBOR, Mich. — Aastrom Biosciences, Inc. , the leading developer of patient-specific expanded multicellular therapies for the treatment of severe chronic cardiovascular diseases, announces the following … more

View todays social media effects on ASTM

View the latest stocks trending across Twitter. Click to view dashboard

See who Aastrom is hiring next, click here to view